Form 8-K - Current report:
SEC Accession No. 0001140361-23-030517
Filing Date
2023-06-20
Accepted
2023-06-20 17:00:48
Documents
13
Period of Report
2023-06-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20054638_8k.htm   iXBRL 8-K 49444
2 EXHIBIT 3.1 brhc20054638_ex3-1.htm EX-3.1 31082
  Complete submission text file 0001140361-23-030517.txt   235199

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20230620.xsd EX-101.SCH 3907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20230620_lab.xml EX-101.LAB 23291
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20230620_pre.xml EX-101.PRE 16580
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054638_8k_htm.xml XML 4372
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 231026087
SIC: 2834 Pharmaceutical Preparations